- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Staidson Beijing Biopharma (300204)
Staidson Beijing Biopharma stock price live, this page displays SZ 300204 stock exchange data. View the 300204 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Staidson Beijing Biopharma real time stock price chart below.
What Is the Staidson Beijing Biopharma Stock Price Today?
The Staidson Beijing Biopharma stock price today is 53.34.
What Is the Stock Symbol for Staidson Beijing Biopharma?
The stock symbol for Staidson Beijing Biopharma is ""300204.""
What Stock Exchange Does Staidson Beijing Biopharma Trade On?
Staidson Beijing Biopharma is listed and trades on the Shenzhen stock exchange.
Is Staidson Beijing Biopharma a Good Stock to Buy?
Determining whether Staidson Beijing Biopharma—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 300204 quote. (ISIN: CNE100001237)
What Is the Staidson Beijing Biopharma Stock Price Today?
The Staidson Beijing Biopharma stock price today is 53.34.
What Is the Stock Symbol for Staidson Beijing Biopharma?
The stock symbol for Staidson Beijing Biopharma is ""300204.""
What Stock Exchange Does Staidson Beijing Biopharma Trade On?
Staidson Beijing Biopharma is listed and trades on the Shenzhen stock exchange.
Is Staidson Beijing Biopharma a Good Stock to Buy?
Determining whether Staidson Beijing Biopharma—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 300204 quote. (ISIN: CNE100001237)
Shenzhen
Currency in CNY
53.34
+1.36(+2.62%)
Closed·
Fair Value
An estimate of a Staidson Beijing Biopharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
50.80
55.55
52 wk Range
5.90
66.66
300204 Scorecard
Full Analysis
Impressive gross profit margins
300204 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Staidson Beijing Biopharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
50.8055.55
52 wk Range
5.9066.66
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
300204 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Staidson Beijing Biopharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
55.24
Upside
+3.56%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with high price volatility
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
Staidson Beijing Biopharma Company Profile
Staidson (Beijing) BioPharmaceuticals Co., Ltd. primarily engages in the research and development, production, and marketing of therapeutic and biological drugs in China. The company offers protein drugs, including therapeutic monoclonal antibody drugs; chemical drugs; and drugs for urinary, intestinal, infectious, autoimmune, nervous system, and other diseases. Its product portfolio includes Mouse Nerve Growth factor for injection, Compound Polyethylene Glycol Electrolyte Powder (IV), Troponium Chloride Capsules, Gliclazide extended-release tablets, Aspirin enteric-coated tablets, Compound polyethylene glycol (3350) electrolyte oral solution, Compound polyethylene glycol (3350) electrolyte vitamin C. Staidson (Beijing) BioPharmaceuticals Co., Ltd. was founded in 2002 and is based in Beijing, China.
Compare 300204 to Peers and Sector
Metrics to compare | 300204 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship300204PeersSector | |
|---|---|---|---|---|
P/E Ratio | −149.6x | −17.4x | −0.6x | |
PEG Ratio | −2.91 | 0.25 | 0.00 | |
Price/Book | 23.7x | 6.8x | 2.6x | |
Price / LTM Sales | 92.7x | 18.6x | 3.3x | |
Upside (Analyst Target) | 6.3% | −3.4% | 39.1% | |
Fair Value Upside | Unlock | −17.2% | 5.4% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 55.24
(+3.56% Upside)
Earnings
Latest Release
Aug 25, 2025
EPS / Forecast
-- / --
Revenue / Forecast
62.38M / --
FAQ
What Stock Exchange Does Staidson Beijing Biopharma Trade On?
Staidson Beijing Biopharma is listed and trades on the Shenzhen Stock Exchange stock exchange.
What Is the Stock Symbol for Staidson Beijing Biopharma?
The stock symbol for Staidson Beijing Biopharma is "300204."
What Is the Staidson Beijing Biopharma Market Cap?
As of today, Staidson Beijing Biopharma market cap is 25.48B.
What Is Staidson Beijing Biopharma's Earnings Per Share (TTM)?
The Staidson Beijing Biopharma EPS (TTM) is -0.30.
From a Technical Analysis Perspective, Is 300204 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Staidson Beijing Biopharma Stock Split?
Staidson Beijing Biopharma has split 4 times.
How Many Employees Does Staidson Beijing Biopharma Have?
Staidson Beijing Biopharma has 492 employees.
What is the current trading status of Staidson Beijing Biopharma (300204)?
As of 29 Aug 2025, Staidson Beijing Biopharma (300204) is trading at a price of 53.34, with a previous close of 51.98. The stock has fluctuated within a day range of 50.80 to 55.55, while its 52-week range spans from 5.90 to 66.66.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.